|
Non-adjusted and age/diagnosis adjusted odds ratio for pharmacological secondary prevention in men with respect to women |
||||
| ORunadj |
C.I. 95% |
ORadj |
C.I. 95% |
|
|
|
||||
| Any medication |
1.63* |
(1.24–2.13) |
1.43* |
(1.07–1.92) |
|
|
||||
| Anticoagulants |
1.93* |
(1.53–2.43) |
1.81* |
(1.41–2.31) |
|
|
||||
| Beta blockers |
1.33* |
(1.10–1.62) |
1.03 |
(0.84–1.27) |
|
|
||||
| ACE inhibitors/ARB |
1.20 |
(0.99–1.45) |
1.15 |
(0.94–1.42) |
|
|
||||
| Lipid-lowering agents |
1.70* |
(1.39–2.05) |
1.24* |
(1.01–1.53) |
|
*p-value < 0,05 in the model adjusted for age and IHD specific diagnosis (chronic ischemic heart disease, acute myocardial infarction and angina) Estimated age-adjusted OR using GAM link logit | ||||
Cruz et al. BMC Family Practice 2008 9:60 doi:10.1186/1471-2296-9-60 |
||||